Methyldibromoglutaronitrile in leave-on products elicits contact allergy at low concentration

Br J Dermatol. 2004 Oct;151(4):817-22. doi: 10.1111/j.1365-2133.2004.06145.x.

Abstract

Background: The rapidly increasing level of contact allergy to methyldibromoglutaronitrile (MDBGN) in Europe is of concern. In April 2003, the EU Commission prohibited the use of MDBGN in leave-on cosmetic products, such as creams and lotions, until a level of safe use can be defined. Industry risk assessment has indicated that such a safe level could be 50-100 p.p.m.

Objectives: To determine whether 50 p.p.m. or 100 p.p.m. could be tolerated by MDBGN-sensitized individuals, and to evaluate if the risk for elicitation of MDBGN allergy is higher for a leave-on product with a high lipid content than for a product with a low lipid content.

Methods: Eighteen volunteers with contact allergy to MDBGN and 10 healthy controls were exposed to repeated open application tests (ROATs) with two moisturizers with a high and a low lipid content, respectively, both containing MDBGN at a concentration of 50 p.p.m. The ROATs were performed on the left and the right side of the neck for 14 days, or until a positive reaction was seen. If a positive reaction did not develop within the first 14 days, two analogous moisturizers containing 100 p.p.m. MDBGN were applied for a further 14 days. Clinical assessments were done on days 2, 3, 7, 14, 21 and 28 or when a reaction developed.

Results: Eleven of 18 (61%) subjects developed dermatitis on the test area, of whom 10 developed a positive reaction to the 50 p.p.m. moisturizer, seven having a positive reaction on day 2 or 3. Reactions to the low-lipid moisturizer were the more frequent. All participants used more of the low-lipid moisturizer than the high-lipid moisturizer. The controls all had negative ROATs.

Conclusions: Even 50 p.p.m. cannot be regarded as a safe concentration for use and the prohibition of MDBGN is scientifically well founded.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cosmetics / toxicity
  • Dermatitis, Allergic Contact / etiology*
  • Dose-Response Relationship, Drug
  • Emollients / toxicity
  • Female
  • Humans
  • Lipids / analysis
  • Male
  • Middle Aged
  • Nitriles / toxicity*
  • Patch Tests / methods
  • Preservatives, Pharmaceutical / toxicity
  • Risk Assessment / methods

Substances

  • Cosmetics
  • Emollients
  • Lipids
  • Nitriles
  • Preservatives, Pharmaceutical
  • 1,2-dibromo-2,4-dicyanobutane